Medicare Enrolled
Dr. Seetal Mewar, M.D.,
Hematology & Oncology · Lake Worth, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mewar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mewar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mewar
Dr. Seetal Mewar is a hematology & oncology in Lake Worth, FL, with 18 years in practice. Based on federal Medicare data, Dr. Mewar performed 19,528 Medicare services across 1,156 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mewar received a total of $22,224 from 98 pharmaceutical and/or device companies across 1168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mewar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 23% volume in FL$ $22,224 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,528
Medicare services
Top 23% in FL for hematology & oncology
1,156
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,085 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 16,500 | $1 | $4 |
| Complete blood count (CBC) with differential | 480 | $8 | $24 |
| Blood draw (venipuncture) | 416 | $8 | $12 |
| Office visit, established patient (30-39 min) | 314 | $94 | $150 |
| Infusion, normal saline solution, 250 cc | 306 | $0 | $7 |
| Comprehensive metabolic blood panel | 278 | $10 | $38 |
| Hospital follow-up visit, high complexity | 174 | $98 | $150 |
| Initial hospital admission, high complexity | 136 | $141 | $280 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 116 | $23 | $175 |
| Ferritin level test (iron stores) | 109 | $13 | $47 |
| Iron level test | 106 | $6 | $30 |
| Transferrin (iron binding protein) level | 106 | $12 | $40 |
| Drug injection, under skin or into muscle | 104 | $11 | $45 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 75 | $50 | $155 |
| Administration of chemotherapy into vein, 1 hour or less | 47 | $105 | $270 |
| Carcinoembryonic antigen (cea) protein level | 46 | $19 | $65 |
| Administration of chemotherapy into vein, each additional hour | 39 | $23 | $90 |
| Lactate dehydrogenase (enzyme) level | 34 | $6 | $15 |
| Vitamin B-12 level test | 30 | $15 | $55 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 29 | $19 | $32 |
| Office visit, established patient, complex (40-54 min) | 26 | $125 | $200 |
| Folic acid level test | 23 | $14 | $32 |
| Red blood count, manual test | 17 | $4 | $18 |
| New patient office visit (45-59 min) | 17 | $137 | $215 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
87.0% high complexity
1.0% medium
12.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,224
Total received (2018-2024)
Avg $3,175/year across 7 years
Top 24% in FL for hematology & oncology
98
Companies
1,168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,321 (91.4%)
Other
Charitable contributions, space rental, and other categories
$1,445 (6.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$458 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,152
2023$3,541
2022$3,142
2021$2,407
2020$2,375
2019$3,087
2018$2,518
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,146
PFIZER INC.
$1,378
AstraZeneca Pharmaceuticals LP
$1,317
E.R. Squibb & Sons, L.L.C.
$1,256
Janssen Biotech, Inc.
$962
Genentech USA, Inc.
$928
Celgene Corporation
$874
Merck Sharp & Dohme LLC
$813
Amgen Inc.
$677
Daiichi Sankyo Inc.
$640
Incyte Corporation
$634
Lilly USA, LLC
$574
Merck Sharp & Dohme Corporation
$555
Astellas Pharma US Inc
$466
Seagen Inc.
$442
EMD Serono, Inc.
$438
Takeda Pharmaceuticals U.S.A., Inc.
$413
JAZZ PHARMACEUTICALS INC.
$387
Bayer HealthCare Pharmaceuticals Inc.
$386
Alexion Pharmaceuticals, Inc.
$359
Eisai Inc.
$358
GENZYME CORPORATION
$351
GlaxoSmithKline, LLC.
$330
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Tempus AI, Inc
$257
Pharmacyclics LLC, An AbbVie Company
$238
Ipsen Biopharmaceuticals, Inc
$232
Sirtex Medical Inc
$231
Boehringer Ingelheim Pharmaceuticals, Inc.
$212
ABBVIE INC.
$202
AbbVie, Inc.
$195
Regeneron Healthcare Solutions, Inc.
$180
Janssen Pharmaceuticals, Inc
$149
Kite Pharma, Inc.
$147
Penumbra, Inc.
$141
ARRAY BIOPHARMA INC
$139
Puma Biotechnology, Inc.
$117
Dova Pharmaceuticals
$114
Karyopharm Therapeutics Inc.
$111
PUMA BIOTECHNOLOGY, INC.
$110
BeiGene USA, Inc.
$104
Exelixis Inc.
$95
Clovis Oncology, Inc.
$94
Helsinn Therapeutics (U.S.), Inc.
$89
Seattle Genetics, Inc.
$88
Mirati Therapeutics, Inc.
$88
Adaptive Biotechnologies Corporation
$87
Taiho Oncology, Inc.
$87
EISAI INC.
$81
TerSera Therapeutics LLC
$77
Pharmacosmos Therapeutics Inc.
$76
SERVIER PHARMACEUTICALS LLC
$73
ADC Therapeutics America, Inc.
$69
SANOFI-AVENTIS U.S. LLC
$66
SOBI, INC
$66
Pharmacyclics LLC, an AbbVie Company
$57
Sobi, Inc
$55
Rigel Pharmaceuticals, Inc.
$54
AbbVie Inc.
$50
PharmaEssentia USA Corporation
$50
Aveo Pharmaceuticals, Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$41
Kyowa Kirin, Inc.
$40
Legend Biotech USA Inc.
$40
Organon LLC
$38
RECORDATI_RARE_DISEASES_INC.
$38
Spectrum Pharmaceuticals Inc.
$37
Stemline Therapeutics Inc.
$37
Blue Earth Diagnostics Limited
$37
CSL Behring
$37
Array BioPharma Inc.
$32
Verastem, Inc.
$29
Amneal Pharmaceuticals LLC
$28
Aurobindo Pharma USA, Inc.
$27
Blueprint Medicines Corporation
$27
Sumitomo Pharma America, Inc.
$27
AMAG Pharmaceuticals, Inc.
$26
Coherus Biosciences Inc.
$26
Global Blood Therapeutics, Inc.
$25
Gilead Sciences, Inc.
$25
Boston Scientific Corporation
$21
Deciphera Pharmaceuticals Inc.
$20
TG Therapeutics, Inc.
$20
Foundation Medicine, Inc.
$20
TESARO, Inc.
$20
Fortovia Therapeutics, Inc.
$19
Ethicon Inc.
$18
Apellis Pharmaceuticals, Inc.
$18
Octapharma USA, Inc.
$17
Mylan Institutional Inc.
$16
Myriad Genetic Laboratories, Inc.
$16
Jazz Pharmaceuticals Inc.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Advanced Accelerator Applications
$15
TOLMAR Pharmaceuticals, Inc.
$14
Dendreon Pharmaceuticals LLC
$13
Agios Pharmaceuticals, Inc.
$12
Teva Pharmaceuticals USA, Inc.
$12
Top 3 companies account for 21.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · Abraxane · Alecensa · Avastin · Axumin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · Indigo System · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kcentra · Kovaltry · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Perjeta · Phesgo · Polivy · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $114 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
40
Per 100K population
2.7
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mewar is a mixed practice specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mewar experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Mewar performed 16,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mewar receive payments from pharmaceutical companies?
Yes. Dr. Mewar received a total of $22,224 from 98 companies across 1,168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mewar's costs compare to other hematology & oncologys in Lake Worth?
Dr. Mewar's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mewar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Lake Worth
Browse hematology & oncologys in Lake Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology